# Northern Biomedical Research, Inc. – FDA Inspection, Mar 29, 2024

Source: https://www.keypedia.com/records/fda_inspections/northern-biomedical-research-inc/01068844-f690-42c0-ad62-cd2bcdb5bea5
Source feed: FDA_Inspections

> FDA inspection 1234502 of Northern Biomedical Research, Inc., March 29, 2024. Classification: Voluntary Action Indicated (VAI). 2 citations under 21 CFR part 58. Form 483 issued. 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1234502
- Company Name: Northern Biomedical Research, Inc.
- Inspection Date: 2024-03-29
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Center: Biologics
- Office Name: Detroit District Office
- Citation Count: 2

## Related Documents

- [FDA Inspection 1324348 - 2026-07-31](https://www.keypedia.com/records/fda_inspections/northern-biomedical-research-inc/e6cb61da-4192-42a3-b970-05be101c71f5)

## Related Officers

- [Company Rep](https://www.keypedia.com/people/chelsea-w-lamm/d7a8dd67-dc26-4c8a-8e3c-aebc267cb775)
- [Company Rep](https://www.keypedia.com/people/dina-a-tallman/e9bf2b98-6697-4d7c-9052-84339536acfd)

Company: https://www.keypedia.com/companies/northern-biomedical-research-inc/28aa90cf-580f-4773-8c36-c7d9f9757991

Office: https://www.keypedia.com/offices/detroit-district-office/b09a1815-a000-40c0-bb44-5432ce87ed03
